electroCore, Inc. Restricted Cash and Cash Equivalents
electroCore, Inc. (ECOR) had Restricted Cash and Cash Equivalents of $250.00 thousand as of 2025-09-30, per its 10-Q filed 2025-11-05.
Financial Statements › Balance Sheet › Assets › Restricted Cash and Cash Equivalent
us-gaap:RestrictedCashAndCashEquivalents · last filed 2025-11-05
- 2025-09-30: Restricted Cash and Cash Equivalents $250.00K.
- 2025-06-30: Restricted Cash and Cash Equivalents $250.00K.
- 2025-03-31: Restricted Cash and Cash Equivalents $250.00K.
- 2024-12-31: Restricted Cash and Cash Equivalents $250.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2025-09-30 | $250.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $250.00K 10-Q · filed 2025-08-06 |
| 2025-03-31 | $250.00K 10-Q · filed 2025-05-07 |
| 2024-12-31 | $250.00K 10-Q · filed 2025-11-05 |
| 2024-03-31 | $8.10M 10-Q · filed 2024-05-08 |
| 2023-12-31 | $250.00K 10-K · filed 2024-03-13 |
| 2023-09-30 | $13.71M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $8.69M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $12.16M 10-Q · filed 2023-05-03 |
| 2022-12-31 | $17.96M 10-K · filed 2023-03-08 |
| 2022-09-30 | $21.89M 10-Q · filed 2023-11-08 |
| 2022-06-30 | $26.58M 10-Q · filed 2023-08-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| EDAP TMS SA (FOCL) | $0.171B | ||
| IRIDEX CORP (IRIX) | United States | $0.011B |